Catalyst Pharmaceuticals (CPRX) Treasury Shares (2014 - 2025)
Catalyst Pharmaceuticals (CPRX) posted Treasury Shares of $752626.0 for Q4 2025, up 6.16% on a QoQ basis from $708960.0 in Q4 2024, and up 6.16% year-over-year from $708960.0 in Q4 2024.
Catalyst Pharmaceuticals (CPRX) Treasury Shares (2014 - 2025) Analysis & Trends
Catalyst Pharmaceuticals' Treasury Shares history runs 10 years deep, the most recent figure standing at $752626.0 for Q4 2025.
- Quarterly Treasury Shares rose 6.16% year-over-year to $752626.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $752626.0 (up 6.16% YoY) and the FY2025 annual result came in at $752626.0, up 6.16% from the prior year.
- Treasury Shares was $752626.0 for Q4 2025 at Catalyst Pharmaceuticals, up from $708960.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $854459.0 in Q4 2023 and bottomed at $67049.0 in Q1 2021.
- A 5-year average of $543072.2 and a median of $730730.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares sank 47.88% — and 2022, when it soared 512.59%.
- Catalyst Pharmaceuticals' Treasury Shares stood at $122839.0 in 2021, then surged by 512.59% to $752500.0 in 2022, then rose by 13.55% to $854459.0 in 2023, then decreased by 17.03% to $708960.0 in 2024, then advanced by 6.16% to $752626.0 in 2025.
- Business Quant data shows CPRX's Treasury Shares at $752626.0 in Q4 2025, $708960.0 in Q4 2024, and $854459.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 752,626.00 |
| Dec 31, 2025 | 752,626.00 |
| Dec 31, 2024 | 708,960.00 |
| Dec 31, 2024 | 708,960.00 |
| Dec 31, 2023 | 854,459.00 |
| Dec 31, 2023 | 854,459.00 |
| Dec 31, 2022 | 752,500.00 |
| Dec 31, 2022 | 752,500.00 |
| Dec 31, 2021 | 122,839.00 |
| Dec 31, 2021 | 122,839.00 |
| Mar 31, 2021 | 67,049.00 |
| Mar 31, 2021 | 67,049.00 |
| Dec 31, 2020 | 235,671.00 |
| Dec 31, 2020 | 235,671.00 |
| Dec 31, 2019 | 352,500.00 |
| Dec 31, 2019 | 352,500.00 |
| Dec 31, 2016 | 26,667.00 |
| Dec 31, 2016 | 26,667.00 |
| Dec 31, 2015 | 53,334.00 |
| Dec 31, 2015 | 53,334.00 |